banner
HCV protease inhibitor Paritaprevir, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ108

HCV protease inhibitor Paritaprevir, Purity ≥98%

Synonym: 1216941-48-8; HCV protease inhibitor; ATB450; ABT-450; ABT 450; Paritaprevir; Veruprevir; Brand name: VIEKIRA PAK

  • CAS Number: 1216941-48-8
  • Compound CID: 45110509
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Paritaprevir, soluble in DMSO, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
765.88
Molecular Formula
C40H43N7O7S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 97 mg/mL (126.64 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Paritaprevir is investigated for its inhibitory effects on the NS3/4A protease, essential for HCV replication, making it a candidate for hepatitis C treatment.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0